Great Point Partners, LLC 13D/13G Filings for Avalo Therapeutics, Inc. (AVTX)

Great Point Partners, LLC 13D and 13G filings for Avalo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
4:36 pm
Sale
2023-12-3113GAVALO THERAPEUTICS INC PAR
AVTX
Great Point Partners, LLC2,085
0.260%
-1,976decrease
(-48.66%)
Filing